IND Investigational New Drug Application
Showing 1 - 25 of >10,000
Alzheimer Trial (Adipose-Derived Mesenchymal Stem Cells)
No longer available
- Alzheimer Disease
- Adipose-Derived Mesenchymal Stem Cells
- (no location specified)
May 3, 2022
Spinal Cord Injury at C5-C7 Level Trial in Houston (HB-adMSCs)
No longer available
- Spinal Cord Injury at C5-C7 Level
- HB-adMSCs
-
Houston, TexasMemorial Hermann Hospital-Clinical Research Unit (MMH-CRU)
Jul 2, 2021
Drug Abuse Trial in Uppsala (Previct Drugs)
Not yet recruiting
- Drug Abuse
- Previct Drugs
-
Uppsala, Uppland, SwedenMottagning för särskild vård, sprutbytet, Husläkarmottagning för
Feb 10, 2023
Drug Abuse Trial in Leiden (Previct Drugs)
Recruiting
- Drug Abuse
- Previct Drugs
-
Leiden, NetherlandsLeiden University Medical Center (LUMC) Department of Anesthesio
Feb 21, 2023
Dysautonomia, Familial, Baroreflex Failure Syndrome Trial in New York (Carbidopa Low-Dose, Placebo, Carbidopa High-Dose)
Completed
- Dysautonomia, Familial
- Baroreflex Failure Syndrome
- Carbidopa Low-Dose
- +2 more
-
New York, New York
- +1 more
Jan 13, 2022
Advanced or Metastatic Solid Tumors Trial in Toulouse, Villejuif, Barcelona (W0101 - Cohort A1, W0101 - Cohort A2, W0101 -
Active, not recruiting
- Advanced or Metastatic Solid Tumors
- W0101 - Cohort A1
- +2 more
-
Toulouse, France
- +2 more
Dec 19, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Birmingham, Alabama
- +25 more
Dec 9, 2022
Sunscreening Agents Trial in Piscataway (ChapStick Active Performance Unscented)
Completed
- Sunscreening Agents
- ChapStick Active Performance Unscented
-
Piscataway, New JerseyGSK Investigational Site
Jul 29, 2022
Sunscreening Agents Trial in Piscataway (ChapStick Lip Moisturizer Original)
Completed
- Sunscreening Agents
- ChapStick Lip Moisturizer Original
-
Piscataway, New JerseyGSK Investigational Site
Jul 29, 2022
Schizophrenia Trial in Oakland Park, Marlton (, SEP-363856, metformin)
Completed
- Schizophrenia
- placebo
- +2 more
-
Oakland Park, Florida
- +1 more
May 31, 2022
Spinocerebellar Ataxia Type 3 Trial in Los Angeles, Tampa (SLS-005, Placebo)
Recruiting
- Spinocerebellar Ataxia Type 3
- SLS-005
- Placebo
-
Los Angeles, California
- +1 more
Aug 4, 2022
Cow's Milk Allergy Trial in Baltimore (Baked non-fat cow's milk powder, Placebo: Tapioca Powder)
Active, not recruiting
- Cow's Milk Allergy
- Baked non-fat cow's milk powder
- Placebo: Tapioca Powder
-
Baltimore, MarylandJohns Hopkins Hospital
Nov 5, 2021
Orofacial Pain Trial in Praha (Transcranial Direct Current Stimulation, Sham Transcranial Direct Current Stimulation)
Recruiting
- Orofacial Pain
- Transcranial Direct Current Stimulation
- Sham Transcranial Direct Current Stimulation
-
Praha, CzechiaPain Management Centre, General University Hospital in Prague; C
Oct 14, 2022
Study of the Use of the Drug Ingaron in Patients With COVID-19
Completed
- COVID-19 Respiratory Infection
- Viral Pneumonia
- Interferon Gamma
-
Moscow, Russian FederationCity Clinical Hospital named after M.E. Zhadkevich Moscow City H
May 23, 2022
Haemophilia A With Inhibitors, Haemophilia B With Inhibitors Trial in Worldwide (Concizumab)
Active, not recruiting
- Haemophilia A With Inhibitors
- Haemophilia B With Inhibitors
-
Orange, California
- +77 more
Dec 29, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)
Active, not recruiting
- Multiple Myeloma
- Belantamab mafodotin frozen liquid
- Belantamab mafodotin lyophilized powder
-
New Haven, Connecticut
- +58 more
Jul 27, 2022
Parkinson's Disease Trial in Worldwide (venglustat GZ/SAR402671, Placebo)
Terminated
- Parkinson's Disease
- venglustat GZ/SAR402671
- Placebo
-
Scottsdale, Arizona
- +51 more
May 3, 2022
Familial Partial Lipodystrophy Trial in Dallas (Obeticholic Acid, Placebo)
Active, not recruiting
- Familial Partial Lipodystrophy
- Obeticholic Acid
- Placebo
-
Dallas, Texas
- +1 more
Jan 23, 2022
HIV Trial in New Zealand, United States (Cabotegravir sodium (Oral Lead In), Cabotegravir 400 mg/mL, Cabotegravir 200 mg/mL)
Recruiting
- HIV Infections
- Cabotegravir sodium (Oral Lead In)
- +6 more
-
Orlando, Florida
- +4 more
Mar 29, 2022